(NASDAQ: CBLL) Ceribell's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.09%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Ceribell's revenue in 2025 is N/A.On average, 2 Wall Street analysts forecast CBLL's revenue for 2025 to be $3,111,191,334, with the lowest CBLL revenue forecast at $3,099,625,567, and the highest CBLL revenue forecast at $3,122,757,101. On average, 2 Wall Street analysts forecast CBLL's revenue for 2026 to be $4,032,838,395, with the lowest CBLL revenue forecast at $3,946,818,002, and the highest CBLL revenue forecast at $4,118,858,787.
In 2027, CBLL is forecast to generate $5,401,574,638 in revenue, with the lowest revenue forecast at $5,401,574,638 and the highest revenue forecast at $5,401,574,638.